NATtrol™ SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL)NATSARS(COV2-SA)-ST
NATtrol™ SARS-related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock is formulated with purified, intact viral particles that have been chemically modified to render them on-infectious and refrigerator stable. Each vial contains 1.0 mL of NATtrol™ SARS-CoV-2 Variant B.1.351 stock in a proprietary matric at the target concentration listed in Table 1.
NATtrol™ SARS-CoV-2 Variant B.1.351 stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARS-CoV-2 Variant B.1.351 RNA. NATtrol™ SARS-CoV-2 Variant B.1.351 stock enables laboratories to monitor test variation, lot-to-lot test kit performance, operator variation, and can provide assistance in identifying random or systematic error.
For Research Use Only